The combination scheme has proven to be efficient in inhibiting the renin-angiotensin system that is mediated by hyperglycemia and in releasing smaller amounts of TGF-β1, which is ultimately involved the development of interstitial fibrosis and mesangial and tubular hypertrophy (202). The gene discussed is REN; the disease is Hyperglycemia.